Contraception
RSSArticles
-
FDA Makes Medication Abortion Available Via Telehealth
The FDA enabled reproductive health providers to prescribe mifepristone, the abortion medication, via telemedicine — at least through the duration of the pandemic. The FDA approved lifting the requirement of in-person dispensing of mifepristone, since the COVID-19 pandemic presents additional COVID-related risks to patients and healthcare personnel when patients visit a clinic solely to receive a prescription.
-
Biden Administration Proposes New Title X Rule
The U.S. Department of Health and Human Services proposed a new Title X rule to ensure access to quality family planning services. The proposed changes would revise the Trump administration’s 2019 rules that Title X advocates say are harmful to women served by these public health services.
-
Positive Contraceptive Outcomes Seen in Teen Pregnancy Prevention Program
A comprehensive intervention for preventing unintended pregnancies among teens led to greater use of long-acting reversible contraception, fewer incidences of unprotected sex, and a big reduction in unintended pregnancies, results of a new study revealed.
-
Cardiovascular Disease Risk Is Increasing Among Reproductive-Age Women
Cardiovascular disease among women of reproductive age has increased in recent years for a variety of reasons, and reproductive health providers should be aware of particular risk factors and issues involving this population. Clinicians should help this high-risk group prevent unplanned pregnancies, researchers noted.
-
Adolescents with HIV Experience High Rates of Unintended Pregnancies
Adolescents living with HIV in the United States are among the groups with the highest rates of adolescent pregnancy. The latest research shows these pregnancies are likely to be unintended. Researchers found 83.6% of pregnancies among HIV-infected adolescents were unintended. Among adult women with HIV in this study, 68.7% experienced unintended pregnancy.
-
Record Number of Reported STD Cases for Sixth Straight Year
U.S. cases of chlamydia, gonorrhea, and syphilis rose almost 30% between 2015 and 2019.
-
FDA Lifts Restriction on Mifepristone Access
Federal rule had required women to pick up the drug in person only, even during the COVID-19 pandemic.
-
Study Reveals Increased IUD Expulsion Rate After Vaginal Delivery
Physicians sometimes worry that women who have not given birth will have more difficulty with an intrauterine device, experiencing a higher expulsion rate. But the results of a recent study show that the opposite is true. -
Ask Women if They Use More than One Contraceptive Method
Nearly one out of five women used two or more methods of contraception the last time they had sexual intercourse, researchers found. Specifically, 18% of women ages 15 to 44 years who had used some form of contraception at last intercourse said they used two or more methods. Condoms and another method were the most commonly used method among dual users (58%). But women also reported using the withdrawal method, or a long-acting reversible contraceptive and another method that did not include condoms or withdrawal. -
SAFE Intervention Brings Reproductive Health Services to Women in Treatment
Women with opioid use disorder may avoid visiting a family planning clinic or seeing a physician for contraceptive care and counseling because of their fear of stigma and judgment. The Sex and Female Empowerment (SAFE) intervention helps this at-risk group receive evidence-based contraceptive information safely and without risk of stigma.